360° SearchNetwork Hot Spots Trends Time Series

Publication: Clinical Lab Products

First reported May 17 2013 - Updated May 17 2013 - 1 reports

CLSI Releases Document to Aid the Detection of Severe Combined Immunodeficiency

NBS06 conveys detailed information for laboratory practice, including calibration, quality control, and proficiency testing. It also addresses program issues such as short-term follow-up (ie, notification andtracking to establish or rule out a diagno ... [Published Clinical Lab Products - May 17 2013]

Entities: Severe Combined Immunodeficiency, Calibration

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Simple New Test Predicts Future Risk for Serious Cardiac Events

Each year, about 1.2 million Americans suffer a heart attack. It is the leading killer of both men and women. ... [Published Clinical Lab Products - May 09 2013]

Entities: Heart Attack

First reported May 08 2013 - Updated May 08 2013 - 1 reports

GenomeDx's Decipher Edges Out Current Risk Assessment Tools in Predicting Metastatic Prostate Cancer, Study Shows

Dr Sharon Ehrmeyer ... [Published Clinical Lab Products - May 08 2013]

Entities: Metastatic, Risk Assessment, Prostate Cancer

First reported May 06 2013 - Updated May 06 2013 - 1 reports

NextLOGiK Tool Helps Medical Practitioners Evaluate the Business of Providing Near-Patient Testing

Medical practices will quickly gain a perspective on their business that typically is reserved for larger lab testing operations, according to the company. ... [Published Clinical Lab Products - May 06 2013]

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Media Campaign in DC Aims to Discourage Youth from Using Fake Weed

Focus Group Data and Report Findings:According to reports from the District of Columbia Prevention Centers, the average age of synthetic marijuana users in the city is 13 years old. Recent focus group findings in partnership with DOH and local youth-based ... [Published Clinical Lab Products - May 03 2013]

Entities: Fake, Cheap, Drugs

First reported May 02 2013 - Updated May 03 2013 - 1 reports

Cancer Genetics Launches Proprietary Microarray for Kidney Cancer

CGI's reference lab is CLIA-certified and accredited by the CAP. ... [Published Clinical Lab Products - May 02 2013]

Entities: kidney cancer, Genetics, Cancer

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Life Technologies Corp

Life Technologies' Instruments FDA-Cleared Under Emergency Use Authorization for Screening of Avian Flu

Dr Sharon Ehrmeyer ... [Published Clinical Lab Products - May 02 2013]

Entities: Life Technologies Corp, Bird Flu, emergency

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Study Finds High Concordance of Genomic Alterations in NSCLC Primary and Matched Metastatic Tumor Pairs

Dr Sharon Ehrmeyer ... [Published Clinical Lab Products - May 01 2013]

Entities: non-small cell lung cancer, Genomics

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Crescendo Bioscience Receives CAP Accreditation

Crescendo Bioscience, South San Francisco, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for rheumatoid arthritis (RA) and other autoimmune diseases, has received accreditation from the Commission on ... [Published Clinical Lab Products - May 01 2013]

Entities: Crescendo Bioscience, Molecular Diagnostics, Rheumatoid Arthritis

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Experts Discuss Role of Molecular Biomarkers in Diagnosis and Staging of Prostate Cancer

"Understanding How New Biomarkers Will Assist in the Diagnosis and Prognosis of Prostate Cancer"Presenters: E. David Crawford, MD, Head Section of Urologic Oncology, professor of urology, surgery, and radiation oncology, University of Colorado School ... [Published Clinical Lab Products - Apr 30 2013]

Entities: Prostate Cancer, Urology, David Crawford, Urologic Oncology

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Johns Hopkins Department of Pathology Will Join PathCentral's New Digital Pathology Network

Dr Sharon Ehrmeyer ... [Published Clinical Lab Products - Apr 29 2013]

Entities: Pathology

First reported Apr 27 2013 - Updated Apr 27 2013 - 1 reports

Sunquest Laboratory Gets 2014 ONC HIT Certification

The ONC 2014 Edition criteria support both Stage 1 and 2 Meaningful Use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).For eligible hospitals, Sunquest says that adding ... [Published Clinical Lab Products - Apr 27 2013]

Entities: Certification, American Recovery & Reinvestment Act, Public Health

Quotes

"Understanding How New Biomarkers Will Assist in the Diagnosis and Prognosis of Prostate Cancer"

Experts Discuss Role of Molecular Biomarkers in Diagnosis and Staging of Prostate Cancer [Published Clinical Lab Products - Apr 30 2013]

"CCHIT congratulates companies successfully achieving EHR technology certification," says Alisa Ray, executive director, CCHIT. "These companies are now able to make their products available to providers wishing to adopt health IT to demonstrate meaningful use and earn federal incentives."

Sunquest Laboratory Gets 2014 ONC HIT Certification [Published Clinical Lab Products - Apr 27 2013]

...by Crescendo," says Stephen Paget, MD, FACP, FACR, physician in chief emeritus, Division of Rheumatology, Hospital for Special Surgery, New York. "Vectra DA can offer insight on disease activity that may not be captured by current standards of RA measurement. Vectra DA brings a deep understanding of the underlying disease biology that can be utilized in the clinic and in clinical trials as we continue to develop potential new treatments for RA patients."

Crescendo Bioscience's Multibiomarker Blood Test for RA Now Available Across the US [Published Clinical Lab Products - Apr 18 2013]

More Content

sort by: Date \| Relevance
CLSI Releases Document to Aid the Detection of ... [Published Clinical Lab Products - May 17 2013]
Simple New Test Predicts Future Risk for Seriou... [Published Clinical Lab Products - May 09 2013]
GenomeDx's Decipher Edges Out Current Risk Asse... [Published Clinical Lab Products - May 08 2013]
NextLOGiK Tool Helps Medical Practitioners Eval... [Published Clinical Lab Products - May 06 2013]
Media Campaign in DC Aims to Discourage Youth f... [Published Clinical Lab Products - May 03 2013]
Cancer Genetics Launches Proprietary Microarray... [Published Clinical Lab Products - May 02 2013]
Life Technologies' Instruments FDA-Cleared Unde... [Published Clinical Lab Products - May 02 2013]
Crescendo Bioscience Receives CAP Accreditation [Published Clinical Lab Products - May 01 2013]
Study Finds High Concordance of Genomic Alterat... [Published Clinical Lab Products - May 01 2013]
Experts Discuss Role of Molecular Biomarkers in... [Published Clinical Lab Products - Apr 30 2013]
Johns Hopkins Department of Pathology Will Join... [Published Clinical Lab Products - Apr 29 2013]
Sunquest Laboratory Gets 2014 ONC HIT Certifica... [Published Clinical Lab Products - Apr 27 2013]
COLA Shines Light on Lab Medicine Careers for Y... [Published Clinical Lab Products - Apr 23 2013]
Calling All Labs: WANTED: Your Lab Week Stories... [Published Clinical Lab Products - Apr 22 2013]
Survey Being Conducted Nationwide on Health Inf... [Published Clinical Lab Products - Apr 19 2013]
Top-Line Data Show Exact Sciences' Cologuard Te... [Published Clinical Lab Products - Apr 18 2013]
Crescendo Bioscience's Multibiomarker Blood Tes... [Published Clinical Lab Products - Apr 18 2013]
Myriad Adopts RainDance's ThunderStorm Platform... [Published Clinical Lab Products - Apr 18 2013]
Beckman Coulter's New Benchtop Hematology Analy... [Published Clinical Lab Products - Apr 16 2013]
Luminex Gets FDA Clearance for MAGPIX Instrumen... [Published Clinical Lab Products - Apr 15 2013]
Recreational Marijuana Users More Likely to Mis... [Published Clinical Lab Products - Apr 13 2013]